Search

iRhythm Technologies Inc

Slēgts

SektorsVeselības aprūpe

123.22 -3.52

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

122.18

Max

125.21

Galvenie mērījumi

By Trading Economics

Ienākumi

14M

-381K

Pārdošana

25M

224M

EPS

0.58

Peļņas marža

-0.17

Darbinieki

2,400

EBITDA

13M

9.7M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+41.61% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 5. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-77M

4B

Iepriekšējā atvēršanas cena

126.74

Iepriekšējā slēgšanas cena

123.22

iRhythm Technologies Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 30. okt. 20:03 UTC

iRhythm Holdings, Inc. shares fell sharply, reaching a session low, in contrast to the prior six sessions that all closed higher.

2026. g. 29. okt. 20:07 UTC

iRhythm Holdings, Inc. shares advanced significantly during Thursday's trading, continuing a climb that began since Wednesday's close and remaining well above its 20-day moving average.

2026. g. 27. okt. 19:56 UTC

iRhythm Holdings, Inc. is trading higher, having reached a peak earlier in the session after four consecutive days of gains, remaining above its 20-day moving average.

2026. g. 23. okt. 20:07 UTC

iRhythm Holdings, Inc. shares are advancing, supported by a strong broader market, and remain above their 20-day moving average.

2026. g. 22. okt. 20:02 UTC

iRhythm Holdings, Inc. is experiencing a sharp increase amid a broader trend of rising daily closes since Wednesday's close.

2026. g. 21. okt. 19:46 UTC

iRhythm Holdings, Inc. shares fell modestly on Wednesday, retracing from an early gain and remaining above the 20-day moving average.

2026. g. 20. okt. 20:01 UTC

iRhythm Holdings, Inc. is trading significantly higher, reaching a session high earlier, and remains above its 20-day moving average.

2026. g. 19. okt. 20:07 UTC

iRhythm Holdings, Inc. is advancing, having gained modestly since Friday's close while trading within the middle of its one-month range.

2026. g. 16. okt. 20:07 UTC

News

Piper Sandler initiated coverage on iRhythm Holdings with an Overweight rating and a price target of $160, citing an overdone year-to-date selloff.

2026. g. 15. okt. 22:56 UTC

News

iRhythm Holdings, Inc. shares declined in after-market hours following Thursday's close, amid broader market trends, ahead of third-quarter results on November 5.

2026. g. 14. okt. 20:31 UTC

Shares down sharply in after-market trading since Wednesday's close.

2026. g. 9. okt. 20:06 UTC

News

iRhythm Holdings is under investigation for a cybersecurity incident and has updated its operational and financial guidance, as shares gain amid a broader market rebound.

2026. g. 8. okt. 20:07 UTC

iRhythm Holdings, Inc. shares are declining, continuing a seven-session downward trend amid ongoing market weakness and remaining significantly below their 20-day moving average.

2026. g. 7. okt. 20:07 UTC

iRhythm Holdings, Inc. shares fell sharply, continuing a six-session decline and remaining significantly below the 20-day moving average.

2026. g. 6. okt. 20:31 UTC

iRhythm Holdings, Inc. is down in after-market trading, marking six consecutive lower daily finishes and trading below its 20-day moving average.

2026. g. 2. okt. 20:07 UTC

iRhythm Holdings, Inc. shares fell modestly as the broader market declined, closing near the lower end of its range and below its 20-day moving average.

2026. g. 1. okt. 20:07 UTC

iRhythm Holdings, Inc. shares fell sharply, reaching a low in the late morning and trading near the lower end of its one-month range.

2026. g. 30. sept. 19:46 UTC

iRhythm Holdings, Inc. shares fell sharply, currently trading below its 20-day moving average and near the lower end of its one-month range.

2026. g. 29. sept. 19:41 UTC

iRhythm Holdings, Inc. is advancing, continuing its upward trend since Monday, amid positive movement in the broader health care equipment sector.

2026. g. 28. sept. 20:01 UTC

iRhythm Holdings, Inc. is advancing, continuing its upward trend since Friday's close, despite mixed performance in the broader health care equipment sector.

2026. g. 23. sept. 19:52 UTC

iRhythm Holdings, Inc. is advancing, continuing a trend of gains since Tuesday's close, despite earlier pulling back from a session high.

2026. g. 21. sept. 19:25 UTC

iRhythm Holdings, Inc. is advancing, continuing gains since Friday's close, despite earlier pulling back from a session high amid broader market strength.

2026. g. 18. sept. 19:16 UTC

iRhythm Holdings, Inc. shares fell sharply, remaining significantly below their 20-day moving average and near the lower end of their one-month trading range.

2026. g. 17. sept. 20:07 UTC

iRhythm Holdings, Inc. shares fell modestly, retracing from an early spike and settling near the lower end of its one-month trading range.

2026. g. 16. sept. 19:16 UTC

iRhythm Holdings, Inc. is trading modestly higher, with a cumulative return peaking at 0.79%, though still below its 20-day moving average.

2026. g. 15. sept. 22:31 UTC

iRhythm Holdings shows little change in after-hours trading, remaining significantly below its 20-day moving average amid broader performance weakness.

2026. g. 14. sept. 20:08 UTC

iRhythm Holdings, Inc. shares are higher today, recovering after five consecutive days of declines, though still below the 20-day moving average.

2026. g. 11. sept. 19:26 UTC

iRhythm Holdings, Inc. shares are lower today, continuing a trend with five consecutive daily declines amid steady inflation data influencing Federal Reserve policy.

2026. g. 10. sept. 20:03 UTC

News

iRhythm Holdings shares are trading lower amid an investigation into potential corporate wrongdoing by the company and certain officers, announced by Bronstein, Gewirtz & Grossman.

2026. g. 9. sept. 20:07 UTC

iRhythm Holdings, Inc. shares are lower amid a volatile session, trading significantly below their 20-day moving average after three consecutive daily declines.

Salīdzinājums

Cenas izmaiņa

iRhythm Technologies Inc Prognoze

Cenas mērķis

By TipRanks

41.61% augšup

Prognoze 12 mēnešiem

Vidējais 174.7 USD  41.61%

Augstākais 196 USD

Zemākais 150 USD

Pamatojoties uz 13 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi iRhythm Technologies Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

13 ratings

13

Pirkt

0

Turēt

0

Pārdot

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat